Jonathan Kaufman MD

School/Division:

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 32

  1. 1
  2. 2
  3. 3
  4. 4

Article

Subcutaneous daratumumab in patients with relapsed or refractory multiple myeloma part 2 of the open-label, multicenter, dose-escalation phase Ib study (PAVO)

by Jonathan Kaufman; J San-Miguel; SZ Usmani; M-V Mateos; NWCJ van de Donk; P Moreau; A Oriol; T Plesner; L Benboubker; K Liu; P Hellemans; T Masterson; PL Clemens; M Luo; A Farnsworth; H Nahi; A Chari

2021

Article

Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN

by Ajay Nooka; Jonathan Kaufman; Cesar Rodriguez; Andrzej Jakubowiak; Yvonne Efebera; Brandi Reeves; Tanya Wildes; Sarah A. Holstein; Larry D. Anderson Jr; Ashraf Badros; Leyla Shune; Ajai Chari; Huiling Pei; Annelore Cortoos; Sharmila Patel; J. Blake Bartlett; Jessica Vermeulen; Thomas S. Lin; Paul G. Richardson; Peter Voorhees

2022

Article

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents

by Roberto Mina; Nisha S. Joseph; Francesca Gay; Efstathios Kastritis; Maria Teresa Petrucci; Jonathan Kaufman; Vittorio Montefusco; Maria Gavriatopoulou; Francesca Patriarca; Paola Omede; Lawrence Boise; Maria Roussou; Nicola Giuliani; Stefania Oliva; Massimo Offidani; Angelo Belotti; David Jaye; Lorenzo De Paoli; Evangelos Terpos; Sagar Lonial; Mario Boccadoro; Ajay Nooka; Meletios A. Dimopoulos

2020

Article

Phase 2 study of venetoclax plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma

by Jonathan Kaufman; LJ Costa; FE Davies; GP Monohan; T Kovacsovics; N Burwick; A Jakubowiak; W-J Hong; M Dail; AH Salem; X Yang; AA Masud; W Munasinghe; JA Ross; OF Bueno; SK Kumar; EA Stadtmauer

2021

Article

Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and in the United States

by Jonathan Kaufman; D Auclair; C Mansfield; MA Fiala; A Chari; CE Cole; GJ Orloff; DS Siegel; JA Zonder; B Mange; J Yesil; M Dalal; JR Mikhael

2022